CPHI Milan 2026

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    The Cost of Uncertainty: How Analytical Chemistry Drives Billion-Dollar Decisions in Pharma

    In pharmaceutical development uncertainty is not an abstract scientific inconvenience It has a cost a timeline a regulatory consequence and ultimately a patient impact A promising medicine may have strong biological rationale compelling early data and significant commercial potential yet still face a fundamental question do we truly understand the product well enough to develop manufacture approve...

    Role of Excipients in Drug Formulation: Functions, Types, and Applications

    Whenever we consider medicines we tend to immediately jump into thinking about the active pharmaceutical ingredients APIs the substances that have therapeutic effects However APIs are not enough to develop stable effective and patientfriendly medicines This is where pharmaceutical excipients would come in The importance of excipients in the case of pharmaceuticals can go well beyond the level

    Antibody-Drug Conjugates (ADCs): Driving the Next Generation of Precision Oncology

    An antibodydrug conjugate is a targeted cancer therapy that links a potent cytotoxic drug to a monoclonal antibody through a chemical linker so the antibody delivers the payload directly to tumour cells expressing a chosen antigen The design widens the therapeutic window it concentrates cytotoxic activity where the target is expressed and limits the systemic exposure that constrains conventional c...

    CyberShield Pharma: Assessing Risks in the Digital Age

    In todays digital age the pharmaceutical industry faces an increasing number of cyber risks With sensitive patient data intellectual property and critical research at stake companies like CyberShield Pharma

    Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

    People respond very differently to medications depending on their weight age inborn capability to metabolize drugs the individual characteristics of the disease or the presence of comorbidities The wellknown assumption that one size fits all has clearly revealed all its limitations and become questionable Notably among humans pediatric patients represent

    How Predictive Maintenance Reduces Downtime in Pharma Plants

    The pharmaceutical industry is always under stress to enhance the reliability of the production adherence to the regulations and quality of the products without raising the prices and to maintain a continuous supply Machinery malfunctions are not merely a setback in this highstakes game they may compromise batch integrity postpone life and death treatments and put pressure on the market promises

TOP ARTICLES

  • 3

    CyberShield Pharma: Assessing Risks in the Digital Age

    Kate Williamson

    "In the digital age, pharmaceutical companies face escalating cyber risks, including data breaches and ransomware attacks. CyberShield Pharma leads in cybersecurity solutions, safeguarding patien...

  • 4

    Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

    Guendalina Zuccari

    Silvana Alfei

    Danilo Marimpietri

    Valentina Iurilli

    Paola Barabino

    Leonardo Marchitto

    In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly manipulated and mixed with food by caregivers at h...

press releases Read more...

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension

ANI Pharmaceuticals Inc ANI or the Company Nasdaq ANIP today announced that it received final approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application

Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity

Wave Life Sciences Ltd Nasdaq WVE a clinicalstage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health today announced the initiation

INFORS HT Launches Multifors 3 bench-top bioreactor for process development

Multifors is what benchscale parallel bioprocessing should look like in Its built around a simple idea the bioreactor should capture and retain the information that matters so scientists can focus

Pretzel Therapeutics Receives FDA Fast Track Designation for PX578 for the Treatment of POLG-mediated Primary Mitochondrial Disorders

Pretzel Therapeutics Inc a clinicalstage biotechnology company advancing a new class of medicines designed to restore mitochondrial function improve cellular energetics and impede disease progression

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

05 - 06

Oct 2026

ISPSAI France 2026

Paris, France

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

12 - 13

Oct 2026

2nd International Conference on Drug Discovery

Village Hotel Changi, Singapor...

LATEST NEWS Read more...

Astoriom Acquires Additional UK Storage Business to Expand Capacity and Services

Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited the UK operations of life sciences stability storage provider Sampled based in Glasgow The acquisition expands

Variant Bio Expands Target Discovery Collaboration with Boehringer Ingelheim into Cardiovascular Disease

Variant Bio has expanded its multiyear research collaboration and licensing agreement with Boehringer Ingelheim to identify and validate new drug targets for cardiovascular disease

SK pharmteco and GEMMABio strengthen rare disease manufacturing collaboration

SK pharmteco has expanded its collaboration with clinicalstage gene therapy company GEMMABio to support the manufacture of materials for the companys Phase CHARISMA clinical trial for spinal muscular

Envisagenics and Boehringer Ingelheim enter multi-target collaboration for cancer therapi

Envisagenics has entered a multiyear research collaboration and option agreement with Boehringer Ingelheim to investigate tumourspecific targets for potential precision therapies for solid tumours

ExploRNA Therapeutics and Łukasiewicz - IChP partner on GMP manufacturing of mRNA cap analogue

ExploRNA Therapeutics has entered a strategic partnership with the ukasiewicz Research Network Industrial Chemistry Institute ukasiewicz IChP to advance the GMP manufacturing of its mRNA cap analogues

PTC Completes Acquisition of ST-920 Gene Therapy for Fabry Disease

PTC Therapeutics has completed its previously announced agreement with Sangamo Therapeutics to acquire ST isaralgagene civaparvovec a onetime AAV gene therapy candidate being developed for Fabry disease